GO:2000339 negative regulation of chemokine (C-X-C motif) ligand 1 production: Inflammatory Signaling Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2000339 describes any biological process that stops, prevents, or reduces the production of CXCL1, a C-X-C motif chemokine also known as KC, SCYB1, or keratinocyte-derived chemokine.
• CXCL1 is a major neutrophil chemoattractant whose excessive production drives neutrophilic airway inflammation, and its negative regulation is critical for resolving inflammation.
• Multiple RNA-binding proteins, including Zfp36 family members and KSRP, restrain CXCL1 production post-transcriptionally by promoting mRNA decay or limiting translation.
• Inhibitory receptors such as LAIR-1 and shRNA-mediated knockdown approaches demonstrate that CXCL1 suppression can be experimentally achieved and functionally validated.
• CXCL1 is not only an inflammatory mediator; it sustains breast cancer stem cell self-renewal and promotes tumor progression and immune escape, making its negative regulation relevant to oncology.
• Studying GO:2000339 requires integrated approaches including CRISPR knockout, RNA-seq, and cytokine profiling to dissect the regulatory layers controlling CXCL1 production.
Description
GO:2000339, negative regulation of chemokine (C-X-C motif) ligand 1 production, is a Gene Ontology biological process term that captures any mechanism capable of stopping, preventing, or reducing the frequency, rate, or extent of CXCL1 production. CXCL1, also known as KC in mice, SCYB1, or keratinocyte-derived chemokine, is a small secreted cytokine belonging to the C-X-C chemokine family that signals primarily through CXCR2 to recruit neutrophils to sites of inflammation. Because unrestrained CXCL1 production contributes to tissue damage in inflammatory diseases and to tumor progression in cancer, understanding the processes that negatively regulate its production is of broad biomedical importance. Research into GO:2000339 spans multiple regulatory layers, including transcriptional repression, post-transcriptional mRNA destabilization, and translational control. For example, the RNA-binding protein KSRP limits the inflammatory response of macrophages by promoting the decay of chemokine transcripts including CXCL1, while Zfp36 family RNA-binding proteins are induced by endothelin-1 in reactive astrocytes and restrain cytokine and chemokine production. In keratinocytes, autophagy enables activation and facilitates wound healing, a process in which chemokine production must be tightly controlled. This article synthesizes the current understanding of GO:2000339 based on published literature, covering the molecular mechanisms that suppress CXCL1 production, the genes and proteins involved, disease contexts in which this regulation is relevant, and the experimental methods, including CRISPR-based models, that researchers use to study it.
negative regulation of chemokine (C-X-C motif) ligand 1 production At A Glance
| GO ID | GO:2000339 |
|---|---|
| GO term | negative regulation of chemokine (C-X-C motif) ligand 1 production |
| Ontology | biological_process |
| Synonym | negative regulation of CXCL1 production; negative regulation of KC production; negative regulation of keratinocyte derived chemokine production; negative regulation of SCYB1 production |
| Major function | Suppression of CXCL1 production to limit neutrophil recruitment and resolve inflammation |
| Regulatory level | Transcriptional, post-transcriptional, and translational control |
| Key mediators | RNA-binding proteins (Zfp36 family, KSRP), inhibitory receptors (LAIR-1), autophagy pathways |
| Disease relevance | Neutrophilic airway inflammation, breast cancer progression, wound healing, neuroinflammation |
What Is GO:2000339?
GO:2000339 is defined by QuickGO as any process that stops, prevents, or reduces the frequency, rate, or extent of chemokine (C-X-C motif) ligand 1 production. In practical terms, this encompasses all cellular mechanisms that lower the amount of CXCL1 protein secreted or synthesized in response to a given stimulus. These mechanisms can act at the level of transcription, mRNA stability, translation, or protein secretion, and they are often triggered by anti-inflammatory signals or by intracellular feedback loops that prevent excessive neutrophil recruitment.
Why Is negative regulation of chemokine (C-X-C motif) ligand 1 production Important in Cell Biology?
GO:2000339 is important because CXCL1 is a potent neutrophil chemoattractant, and its overproduction is a hallmark of many inflammatory diseases, including neutrophilic airway inflammation where LAIR-1 has been shown to limit neutrophil recruitment by suppressing chemokine production. In cancer, CXCL1 sustains breast cancer stem cell self-renewal and promotes tumor progression and immune escape, and adipocyte-derived IL6 together with tumor-derived CXCL1 co-activate STAT3/NF-kB signaling to mediate crosstalk between adipocytes and triple-negative breast cancer cells. Understanding the negative regulation of CXCL1 production therefore offers therapeutic opportunities to dampen pathological inflammation and to disrupt tumor-promoting microenvironments.
• Limits neutrophilic airway inflammation by reducing CXCL1-mediated neutrophil recruitment.
• Prevents excessive tissue damage during wound healing by controlling keratinocyte-derived chemokine production.
• Restrains tumor progression and immune escape in breast cancer by suppressing CXCL1-driven stem cell self-renewal.
• Modulates the crosstalk between adipocytes and triple-negative breast cancer cells through the IL6-CXCL1-STAT3/NF-kB axis.
• Controls neuroinflammation by regulating chemokine production in reactive astrocytes.
• Provides a mechanism for anti-inflammatory feedback in macrophages via KSRP-mediated mRNA decay.
• Offers a target for shRNA or CRISPR-based interventions to reduce CXCL1 production in inflammatory diseases.
• Helps explain how preconditioning-induced neuroprotection depends on tightly regulated chemokine expression.
• Guides the development of therapeutics that modulate chemokine networks without fully ablating immune responses.
• Enables researchers to dissect post-transcriptional regulatory networks that control inflammatory gene expression.
What Happens During negative regulation of chemokine (C-X-C motif) ligand 1 production?
Initiation by anti-inflammatory or feedback signals
In simple terms: The process starts when a cell receives a signal telling it to stop making CXCL1.
Negative regulation of CXCL1 production is initiated by diverse signals, including inhibitory receptor engagement, anti-inflammatory cytokines, and intracellular feedback loops. For example, LAIR-1, an inhibitory receptor, limits neutrophilic airway inflammation by suppressing chemokine production. In reactive astrocytes, endothelin-1 induces Zfp36 family RNA-binding proteins that restrain cytokine and chemokine production. These initiating signals set in motion molecular events that reduce CXCL1 synthesis.
Transcriptional suppression of CXCL1 gene expression
In simple terms: The cell reduces the reading of the CXCL1 gene into messenger RNA.
One layer of negative regulation occurs at the level of transcription, where repressors or reduced activity of activating transcription factors lowers CXCL1 mRNA synthesis. Although the exact transcription factors vary by cell type, the outcome is a decrease in the frequency and rate of CXCL1 production as defined by GO:2000339. In macrophages, the mRNA-binding protein KSRP limits the inflammatory response by promoting the decay of chemokine transcripts, indirectly reflecting reduced transcript availability.
Post-transcriptional mRNA destabilization
In simple terms: The messenger RNA for CXCL1 is destroyed faster, so less protein can be made.
RNA-binding proteins play a central role in post-transcriptional negative regulation. KSRP (also known as KHSRP) binds to AU-rich elements in chemokine mRNAs and promotes their degradation, thereby limiting the inflammatory response of macrophages. Similarly, Zfp36 family proteins, induced by endothelin-1 in reactive astrocytes, bind to mRNA and restrain cytokine and chemokine production. These mechanisms reduce the half-life of CXCL1 mRNA, directly lowering the extent of CXCL1 production.
Translational repression and protein secretion control
In simple terms: Even if some messenger RNA remains, the cell can block its translation into protein or reduce secretion.
Beyond mRNA stability, negative regulation can occur at the level of translation or secretion. Although specific translational repressors of CXCL1 are less well characterized, the general principle is that reduced translation initiation or enhanced protein degradation lowers secreted CXCL1 levels. In keratinocytes, autophagy enables activation and facilitates wound healing, a process in which chemokine production is tightly controlled. This suggests that autophagic pathways may intersect with the regulation of chemokine output.
Functional consequences: reduced neutrophil recruitment
In simple terms: With less CXCL1, fewer neutrophils are called to the site, which reduces inflammation.
The ultimate functional consequence of negative regulation of CXCL1 production is reduced neutrophil chemotaxis and recruitment. LAIR-1-mediated suppression of chemokine production limits neutrophilic airway inflammation, demonstrating that this regulatory process has direct physiological impact. In cancer, suppressing CXCL1 production can reduce breast cancer stem cell self-renewal and disrupt tumor-promoting crosstalk with adipocytes. Thus, GO:2000339 encompasses mechanisms that translate molecular suppression into tissue-level outcomes.
Key Genes Involved in GO:2000339 negative regulation of chemokine (C-X-C motif) ligand 1 production
The following genes and proteins are experimentally implicated in the negative regulation of CXCL1 production or in the broader control of CXCL1 biology.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CXCL1 | Encodes the chemokine whose production is negatively regulated | Central target of GO:2000339; measured as readout in knockout and knockdown studies |
| KHSRP (KSRP) | RNA-binding protein that promotes decay of chemokine mRNAs | Limits inflammatory response in macrophages; key post-transcriptional regulator |
| ZFP36 | RNA-binding protein induced by endothelin-1; restrains cytokine and chemokine production | Regulates chemokine output in reactive astrocytes |
| ZFP36L1 | Zfp36 family RNA-binding protein | Contributes to post-transcriptional restraint of chemokine production |
| ZFP36L2 | Zfp36 family RNA-binding protein | Contributes to post-transcriptional restraint of chemokine production |
| LAIR1 | Inhibitory receptor that limits neutrophilic airway inflammation | Suppresses chemokine production; studied in airway inflammation models |
| MYD88 | Adaptor protein in TLR/IL-1 signaling | Preconditioning-induced neuroprotection depends on MyD88-mediated chemokine expression |
| IL6 | Adipocyte-derived cytokine that co-activates STAT3/NF-kB with CXCL1 | Mediates crosstalk between adipocytes and triple-negative breast cancer cells |
| STAT3 | Transcription factor activated by IL6 and CXCL1 | Part of the signaling axis that can be modulated by CXCL1 levels |
| NFKB1 | Transcription factor subunit involved in inflammatory gene expression | Co-activated by IL6 and CXCL1 in tumor microenvironment |
| ATG5 | Autophagy-related protein | Autophagy in keratinocytes enables activation and wound healing, indirectly affecting chemokine control |
| ATG7 | Autophagy-related protein | Autophagy pathway component relevant to keratinocyte function and chemokine regulation |
| CXCR2 | Receptor for CXCL1 | Mediates neutrophil recruitment; downstream effector of CXCL1 |
| MAPK1 | Kinase in inflammatory signaling pathways | Potential modulator of chemokine production; studied in inflammation contexts |
| RELA | NF-kB subunit | Transcription factor involved in CXCL1 gene expression; target of negative regulation |
| TNFA | Pro-inflammatory cytokine | Stimulates CXCL1 production; its suppression is part of negative regulation |
| IL1B | Pro-inflammatory cytokine | Induces CXCL1; negative regulation counteracts this induction |
How Is negative regulation of chemokine (C-X-C motif) ligand 1 production Regulated?
The negative regulation of CXCL1 production is itself regulated at multiple levels. Inhibitory receptors such as LAIR-1 can be engaged by ligands to suppress chemokine production. Endothelin-1 induces Zfp36 family RNA-binding proteins, which then restrain cytokine and chemokine production in reactive astrocytes. In macrophages, KSRP levels or activity determine the extent to which chemokine mRNAs are degraded. Additionally, autophagy pathways in keratinocytes are required for proper activation and wound healing, suggesting that autophagic flux can influence chemokine output. These regulatory inputs ensure that CXCL1 production is tuned to the inflammatory context.
negative regulation of chemokine (C-X-C motif) ligand 1 production and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| LAIR1 | Neutrophilic airway inflammation | LAIR-1 knockout mice or airway epithelial cell lines with LAIR-1 overexpression |
| CXCL1 | Breast cancer progression and immune escape | Triple-negative breast cancer cell lines with CXCL1 knockout or knockdown |
| KHSRP | Macrophage inflammatory response | KSRP knockout macrophages or CRISPR knockout in monocytic cell lines |
| ZFP36 | Neuroinflammation in reactive astrocytes | Astrocyte cultures with Zfp36 family knockout or overexpression |
| ATG5 | Wound healing and keratinocyte activation | Keratinocyte-specific Atg5 knockout mice or cell lines |
Neutrophilic airway inflammation
LAIR-1 limits neutrophilic airway inflammation by suppressing chemokine production, indicating that negative regulation of CXCL1 is a critical brake on neutrophil recruitment in the lung. Dysregulation of this process could lead to excessive airway neutrophilia and tissue damage.
Breast cancer progression and immune escape
CXCL1 sustains breast cancer stem cell self-renewal and promotes tumor progression and immune escape. Adipocyte-derived IL6 and tumor-derived CXCL1 co-activate STAT3/NF-kB signaling, mediating crosstalk between adipocytes and triple-negative breast cancer cells. Therefore, negative regulation of CXCL1 production may suppress tumor-promoting inflammation and stemness.
Neuroinflammation and neuroprotection
In reactive astrocytes, endothelin-1 induces Zfp36 family proteins that restrain cytokine and chemokine production, including CXCL1. Preconditioning-induced neuroprotection in mice depends on MyD88-mediated CXCL10 expression in endothelial cells, highlighting the importance of tightly regulated chemokine networks in the brain.
Wound healing and keratinocyte biology
Keratinocyte autophagy enables the activation of keratinocytes and fibroblasts and facilitates wound healing. Proper control of chemokine production, including CXCL1, is likely part of this process, as excessive or prolonged chemokine signaling can impair tissue repair.
From negative regulation of chemokine (C-X-C motif) ligand 1 production-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X negatively regulate CXCL1 production? | CRISPR knockout of gene X in macrophages or epithelial cells followed by CXCL1 ELISA |
| Does a specific point mutation in a regulator alter CXCL1 suppression? | Point-mutation knock-in via CRISPR in cell lines |
| Does overexpression of a candidate repressor reduce CXCL1? | Overexpression cell model with doxycycline-inducible vector |
| Does a tagged regulator bind CXCL1 mRNA? | Tagged knock-in of RNA-binding protein followed by RIP-seq |
| Does LAIR-1 signaling suppress CXCL1 in vivo? | LAIR-1 knockout or transgenic mice in airway inflammation models |
| Does autophagy modulate chemokine production during wound healing? | Keratinocyte-specific autophagy gene knockout mice |
How to Study the negative regulation of chemokine (C-X-C motif) ligand 1 production Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss of gene function | Testing whether a candidate gene is required for CXCL1 suppression |
| shRNA knockdown | Reduction of target gene expression | Suppressing CXCL1 production directly or knocking down regulators |
| RNA-seq | Global transcript levels | Identifying changes in CXCL1 and other chemokines after perturbation |
| ELISA | Secreted CXCL1 protein concentration | Quantifying the extent of CXCL1 production in supernatants |
| RIP-seq | RNA targets of an RNA-binding protein | Mapping direct binding of KSRP or Zfp36 to CXCL1 mRNA |
| mRNA stability assay | Rate of mRNA decay | Determining whether negative regulation occurs post-transcriptionally |
| Western blot | Protein expression levels | Validating knockout or overexpression of regulatory proteins |
| Flow cytometry | Cell surface markers and intracellular proteins | Assessing immune cell recruitment in inflammation models |
CRISPR knockout and knockdown for functional validation
CRISPR-Cas9 knockout of candidate negative regulators, such as KHSRP or ZFP36 family genes, followed by measurement of CXCL1 mRNA and protein, can determine whether a gene is required for suppression of CXCL1 production. shRNA-based knockdown has also been used to suppress CXCL1 directly, demonstrating the feasibility of reducing its production.
RNA-seq and transcriptomic profiling
RNA-seq can quantify CXCL1 mRNA levels and identify global changes in chemokine networks upon perturbation of regulatory genes. This approach is useful for discovering novel negative regulators and for confirming that changes in CXCL1 production are accompanied by coordinated changes in other inflammatory genes.
Cytokine profiling by ELISA and Luminex
Measuring secreted CXCL1 protein in culture supernatants or serum using ELISA or multiplex assays provides a direct readout of the extent of CXCL1 production. This method is widely used to validate negative regulation in knockout or overexpression models.
RNA immunoprecipitation and mRNA stability assays
RNA immunoprecipitation (RIP) followed by qPCR or sequencing can demonstrate direct binding of RNA-binding proteins such as KSRP or Zfp36 family members to CXCL1 mRNA. mRNA stability assays using actinomycin D can then show whether binding leads to accelerated decay, a key mechanism of negative regulation.
How CRISPR Can Be Used to Study GO:2000339 negative regulation of chemokine (C-X-C motif) ligand 1 production
Knockout
CRISPR knockout of genes such as KHSRP, ZFP36, or LAIR1 can reveal whether they are necessary for the negative regulation of CXCL1 production. For example, KSRP knockout macrophages would be expected to show increased chemokine mRNA stability and elevated CXCL1 secretion, confirming its role in limiting inflammation. Similarly, LAIR-1 knockout could exacerbate neutrophilic airway inflammation due to loss of chemokine suppression.
Point Mutation
Point mutations can be introduced into regulatory proteins to dissect domain-specific functions. For instance, mutating the RNA-binding domain of KSRP or Zfp36 family proteins would test whether direct mRNA binding is required for suppressing CXCL1 production. Such models help distinguish between binding-dependent and independent mechanisms.
Knock-in
Knock-in of epitope tags or fluorescent reporters into endogenous loci allows tracking of regulatory proteins and their interaction with CXCL1 mRNA. A tagged KSRP knock-in cell line could be used for RIP-seq to identify direct targets, including CXCL1, under inflammatory conditions. Similarly, tagging Zfp36 family members could reveal their dynamics in reactive astrocytes.
Overexpression
Overexpression of candidate negative regulators, such as KSRP or Zfp36, can test whether increasing their levels is sufficient to reduce CXCL1 production. This approach is useful for validating gain-of-function effects and for identifying therapeutic targets that could be upregulated to dampen inflammation.
How EDITGENE Supports negative regulation of chemokine (C-X-C motif) ligand 1 production Research
Researchers studying negative regulation of chemokine (C-X-C motif) ligand 1 production-related genes often need to determine whether a candidate gene is causally involved in suppressing CXCL1, and whether this suppression occurs at the transcriptional, post-transcriptional, or translational level. EDITGENE provides a comprehensive suite of CRISPR-based services to enable these investigations, from knockout and point-mutation models to overexpression and library screening.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of chemokine (C-X-C motif) ligand 1 production research.
Frequently Asked Questions About negative regulation of chemokine (C-X-C motif) ligand 1 production
What is GO:2000339?
GO:2000339 is a Gene Ontology biological process term defined as any process that stops, prevents, or reduces the frequency, rate, or extent of chemokine (C-X-C motif) ligand 1 production.
What is CXCL1?
CXCL1 is a C-X-C motif chemokine also known as KC, SCYB1, or keratinocyte-derived chemokine, which recruits neutrophils by signaling through CXCR2.
What genes are involved in negative regulation of CXCL1 production?
Genes such as KHSRP (KSRP), ZFP36 family members, and LAIR1 have been implicated in suppressing CXCL1 production through post-transcriptional or receptor-mediated mechanisms.
Why is negative regulation of CXCL1 important?
It prevents excessive neutrophil recruitment and tissue damage during inflammation and can limit tumor progression and immune escape in cancer.
How is CXCL1 production negatively regulated at the mRNA level?
RNA-binding proteins such as KSRP and Zfp36 family members bind to CXCL1 mRNA and promote its degradation, reducing the amount of protein produced.
What diseases are associated with dysregulated CXCL1 production?
Neutrophilic airway inflammation, breast cancer progression, neuroinflammation, and impaired wound healing have all been linked to altered CXCL1 regulation.
How can CRISPR be used to study negative regulation of CXCL1?
CRISPR knockout of candidate regulators, such as KHSRP or ZFP36, followed by CXCL1 measurement, can determine whether a gene is required for suppression of CXCL1 production.
What experimental models are suitable for studying GO:2000339?
Macrophage cell lines, airway epithelial cells, astrocytes, keratinocytes, and breast cancer cell lines are commonly used, often with CRISPR knockout or overexpression of regulatory genes.
Does LAIR-1 regulate CXCL1 production?
Yes, LAIR-1 is an inhibitory receptor that limits neutrophilic airway inflammation by suppressing chemokine production, including CXCL1.
What is the role of autophagy in CXCL1 regulation?
Keratinocyte autophagy enables activation and wound healing, a context in which chemokine production must be controlled, suggesting an indirect role in regulating CXCL1 output.
Conclusion
GO:2000339, negative regulation of chemokine (C-X-C motif) ligand 1 production, represents a critical control point in inflammatory and cancer biology. The process is mediated by a network of transcriptional, post-transcriptional, and translational mechanisms, with RNA-binding proteins such as KSRP and Zfp36 family members playing central roles. Inhibitory receptors like LAIR-1 provide an additional layer of control, particularly in neutrophilic airway inflammation. Dysregulation of this process contributes to breast cancer progression, neuroinflammation, and impaired wound healing. Researchers can leverage CRISPR-based knockout, point-mutation, knock-in, and overexpression models to dissect the molecular players involved in suppressing CXCL1 production. Combined with RNA-seq, cytokine profiling, and RNA immunoprecipitation, these approaches enable a comprehensive understanding of how CXCL1 is kept in check and how this regulation can be harnessed therapeutically.
References
- 1. Qiang L et al.. 2021. Keratinocyte autophagy enables the activation of keratinocytes and fibroblastsand facilitates wound healing.. Autophagy 17(9):2128-2143 PMID: 32866426
- 2. Ciummo SL et al.. 2021. The C-X-C Motif Chemokine Ligand 1 Sustains Breast Cancer Stem Cell Self-Renewal and Promotes Tumor Progression and Immune Escape Programs.. Front Cell Dev Biol 9:689286 PMID: 34195201
- 3. Kumawat K et al.. 2019. LAIR-1 Limits Neutrophilic Airway Inflammation.. Front Immunol 10:842 PMID: 31080449
- 4. Elgreu T et al.. 2026. Suppression of Lipopolysaccharide-Induced Cytokine Production by Chemokine Ligand-1 Short Hairpin RNA.. J Interferon Cytokine Res 46(9):272-277 PMID: 42544596
- 5. Koyama Y et al.. 2026. Endothelin-1 induces Zfp36 family RNA-binding proteins and restrains cytokine and chemokine production in reactive astrocytes.. J Biol Chem 302(5):111424 PMID: 41935833
- 6. Ruan GT et al.. 2025. Adipocyte-derived IL6 and triple-negative breast cancer cell-derived CXCL1 co-activate STAT3/NF-κB pathway to mediate the crosstalk between adipocytes and triple-negative breast cancer cells.. Cell Death Discov 11(1):395 PMID: 40841364
- 7. Chen Z et al.. 2023. Neuroprotection by Preconditioning in Mice is Dependent on MyD88-Mediated CXCL10 Expression in Endothelial Cells.. ASN Neuro 15:17590914221146365 PMID: 36591943
- 8. Bolduan V et al.. 2024. The mRNA-Binding Protein KSRP Limits the Inflammatory Response of Macrophages.. Int J Mol Sci 25(7) PMID: 38612694
